Under an Investigational New Drug Application (IND), Skingenix has successfully completed two pilot clinical studies in USA :
- First clinical study was conducted in patients with Venous Leg Ulcer.
- The second clinical study was conducted in patients with Diabetic Foot Ulcers.
These studies were completed in December 2011.